Paper35106968
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis.
Grayson PC and 11 others. Arthritis Rheumatol, 2022. Cited by 163 papers, by iCite.
Cite this record
ConductScience Library. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis. Papers, record 35106968. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35106968
- Disease
- eosinophilic granulomatosis with polyangiitis19 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis.
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Churg-Strauss Syndrome | Major topic |
| Adult | |
| Aged | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Sensitivity and Specificity |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| MR/N011775/1 | Medical Research Council | United Kingdom | PubMed | PubMed | |
| ZIAAR041204 | NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT07591753 | Long-Term Safety and Effectiveness of Mepolizumab 300 mg in Europe (Mepo LTF Study) | Results |
Source ClinicalTrials.gov
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 35106953 | New Classification Criteria for Small-Vessel Vasculitis: Is Antineutrophil Cytoplasmic Antibody Inclusion Their Major Advance? | https://conductscience.org/library/papers/35106953 | PubMed |
| Comment in | 35714043 | A methodologic problem and a conceptual issue related to the new 2022 antineutrophil cytoplasmic antibody-related vasculitis criteria sets: comment on criteria sets approved by the American College of Rheumatology Board of Directors and the European Alliance of Associations for Rheumatology Executive Committee. | https://conductscience.org/library/papers/35714043 | PubMed |
Cited by86
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 163 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42893335 | Beyond Pneumonia: A Case of Steroid-Responsive Pulmonary Eosinophilia With Atypical p-ANCA Positivity. | Cureus | 2026 | https://conductscience.org/library/papers/42893335 | PubMed |
| 42871696 | When Eosinophilic Granulomatosis With Polyangiitis (EGPA) Looks Like Granulomatosis With Polyangiitis (GPA): Navigating a Complex Case of Anti-neutrophil Cytoplasmic Antibodies (ANCA) Vasculitis. | Cureus | 2026 | https://conductscience.org/library/papers/42871696 | PubMed |
| 42827517 | Bronchiectasis as the Sentinel Manifestation of ANCA-Associated Vasculitis: A Case Report and Literature Review. | Respirol Case Rep | 2026 | https://conductscience.org/library/papers/42827517 | PubMed |
| 42824523 | Life-Threatening Eosinophilic Granulomatosis With Polyangiitis During Omalizumab Therapy for Chronic Urticaria: Missed Diagnosis, Induction, or Unmasking? | Cureus | 2026 | https://conductscience.org/library/papers/42824523 | PubMed |
| 42806340 | Identification of clinical-biological endophenotypes in patients with eosinophilic granulomatosis with polyangiitis using unsupervised machine learning: a real-world study. | Respir Res | 2026 | https://conductscience.org/library/papers/42806340 | PubMed |
| 42666554 | New perspectives in the treatment of chronic eosinophilic pneumonia in the era of targeted therapies. | Front Immunol | 2026 | https://conductscience.org/library/papers/42666554 | PubMed |
| 42653119 | EGPA at Diagnosis: A Comprehensive Single-Center Profile of Laboratory Findings and Clinical Evidence. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42653119 | PubMed |
| 42568486 | Eosinophilic granulomatosis with polyangiitis complicated by pulmonary aspergillosis and misdiagnosed as allergic bronchopulmonary aspergillosis: a case report. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42568486 | PubMed |
| 42558283 | Mortality risk stratification in antineutrophil cytoplasmic antibody-associated vasculitis: baseline severity, accumulated damage burden and cardio-renal vulnerability in a Chinese two-center cohort. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42558283 | PubMed |
| 42487962 | Case Report: From misdiagnosis to successful treatment using mepolizumab in ANCA-negative severe EGPA-clinical lessons in eosinophil-targeted therapy. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42487962 | PubMed |
| 42417783 | Factors Associated With the High Prevalence of Metabolic Syndrome in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. | Arq Bras Cardiol | 2026 | https://conductscience.org/library/papers/42417783 | PubMed |
| 42396140 | Beyond clinical criteria: emerging biomarkers and advanced imaging in the diagnosis, monitoring and treatment of vasculitides. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42396140 | PubMed |
| 42367766 | Biological functions and clinical efficacy of IL-5/IL-5Rα-targeted therapies across eosinophilia-associated diseases. | Front Immunol | 2026 | https://conductscience.org/library/papers/42367766 | PubMed |
| 42346872 | Renal Involvement in Pediatric Small-Vessel Vasculitis: A Comprehensive Review of Clinical Impact, Diagnosis, and Management. | Med Sci (Basel) | 2026 | https://conductscience.org/library/papers/42346872 | PubMed |
| 42190692 | The SHIPE Index: A Tertile-Based Approach to Predict End-Stage Kidney Disease in ANCA-Associated Vasculitis. | J Korean Med Sci | 2026 | https://conductscience.org/library/papers/42190692 | PubMed |
| 42137655 | Eosinophilic Granulomatosis With Polyangiitis (EGPA) Manifesting as Giant Cell Arteritis After Initiating Treatment With Dupilumab: An Unusual Clinical Presentation. | Cureus | 2026 | https://conductscience.org/library/papers/42137655 | PubMed |
| 42051495 | Expert review and recommendations on the diagnosis and therapeutic management of eosinophilic granulomatosis with polyangiitis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42051495 | PubMed |
| 42011880 | Monoclonal antibodies targeting IL-5/5R or IL-4/13 pathways in eosinophilic myocarditis: a single-centre experience and systematic literature review. | Eur Heart J Cardiovasc Pharmacother | 2026 | https://conductscience.org/library/papers/42011880 | PubMed |
| 42004946 | Long-term outcomes remain unchanged despite reduced glucocorticoid exposure in ANCA-associated vasculitis: the multicentre REVEAL cohort study. | Front Immunol | 2026 | https://conductscience.org/library/papers/42004946 | PubMed |
| 41947311 | Cochlear Implantation in Autoimmune Inner-Ear Disease: Outcome and Patient-Reported Benefit. | Laryngoscope | 2026 | https://conductscience.org/library/papers/41947311 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PRTN3 | 5657 | PubTator's text mining | https://conductscience.org/library/genes/5657 |
Source NCBI Gene
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| MEPOLIZUMAB | CHEMBL2108429 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL2108429 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- References
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35106968
GET https://conductscience.org/api/papers/v1/35106968/cited_by?page=2